Preferred Label : simethicone;

MeSH definition : A poly(dimethylsiloxane) which is a polymer of 200-350 units of dimethylsiloxane, along with added silica gel. It is used as an antiflatulent, surfactant, and ointment base.;

MeSH hyponym : phazyme 125;

Registry Number MeSH : 8050-81-5;

Wikipedia link : https://en.wikipedia.org/wiki/Simethicone;

Is substance : O;

Details


Main resources

You can consult :

A poly(dimethylsiloxane) which is a polymer of 200-350 units of dimethylsiloxane, along with added silica gel. It is used as an antiflatulent, surfactant, and ointment base.

https://www.has-sante.fr/portail/jcms/c_2862072/fr/ximepeg
2018
false
false
false
false
France
French
evaluation of the transparency committee
drug therapy, combination
drug combinations
simethicone
polyethylene glycol 4000
insurance, health, reimbursement
sodium sulfate
citric acid
sodium chloride
potassium chloride
electrolytes
administration, oral
enema
combinations
adult
polyethylene glycol 4000
polyethylene glycols
sulfates
citrates
Sodium Citrate

---
http://www.has-sante.fr/portail/jcms/c_2628022/fr/carbosymag
http://www.has-sante.fr/portail/jcms/c_1717925/fr/carbosymag
http://www.has-sante.fr/portail/jcms/c_1221588/carbosymag
http://www.has-sante.fr/portail/jcms/c_603003/carbosymag
2016
false
France
French
administration, oral
antacids
antifoaming agents
charcoal
magnesium oxide
simethicone
drug combinations
drug therapy, combination
insurance, health, reimbursement
antacids, other combinations
treatment outcome
heartburn
flatulence
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_1190367/meteoxane
http://www.has-sante.fr/portail/jcms/c_1075793/meteoxane
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-11/meteoxane_ct_9800.pdf
http://www.has-sante.fr/portail/jcms/c_1735573/fr/meteoxane
2014
France
French
English
evaluation of the transparency committee
drug combinations
administration, oral
phloroglucinol
simethicone
antifoaming agents
parasympatholytics
other drugs for functional gastrointestinal disorders
treatment outcome
insurance, health, reimbursement
diarrhea
flatulence
abdominal pain
colonic diseases, functional

---
http://www.has-sante.fr/portail/jcms/c_1277923/meteospasmyl
http://www.has-sante.fr/portail/jcms/c_952656/meteospasmyl
http://www.has-sante.fr/portail/jcms/c_1648972/fr/meteospasmyl
http://www.has-sante.fr/portail/jcms/c_1716208/fr/meteospasmyl
http://www.has-sante.fr/portail/jcms/c_1716207/fr/meteospasmyl18122013avisct12447
2013
France
French
alverine
drug combinations
alverine, combinations
simethicone
adult
administration, oral
antifoaming agents
parasympatholytics
flatulence
colonic diseases, functional
treatment outcome
insurance, health, reimbursement
propylamines
alverine citrate
evaluation of the transparency committee

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67275135
2010
France
French
administration, oral
drug combinations
loperamide
simethicone
loperamide
simethicone
antidiarrheals
antidiarrheals
adult
adolescent
aged
loperamide, combinations
antifoaming agents
antifoaming agents
pregnancy
breast feeding
summary of product characteristics
package leaflet

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct031993.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_400416
2005
France
French
evaluation of the transparency committee
child
adult
administration, oral
simethicone
charcoal
treatment outcome
drug combinations
medicinal charcoal, combinations
dyspepsia
flatulence

---
Nous contacter.
23/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.